News About: Pharm. Industry
BMI Korea releases cross-linked hyaluronic acid anti-adhesion barrierBMI Korea, a local biopharmaceutical company, said Friday that it has started selling Hibarry, a cross-linked hyaluronic acid anti-adhesion barrier.
Developed by BNC Korea, H...
|
One out of every 70 employees becomes unregistered executive at domestic pharmaceutical firms
Yakup.com, an on-line pharmaceutical information provider, said Thursday that many employees strive to become an executive, but one out of every 70 employees at Korea’s 56 listed pharmaceutical companies went up to th...
25% of pharmaceutical CEOs are pharmacy college graduates
One out of four chief executive officers (CEOs) at Korea’s 56 listed pharmaceutical firms graduated from pharmacy college, according to Yakup.com, a pharmaceutical information portal.
The portal said that about 40 ...
Generation shift in Dong-A
The nation’s major pharmaceutical company is undergoing a generation shift that will bring changes to the local pharmaceutical industry landscape.
Dong-A Socio Group Chairman Kang Shin-ho on Thursday handed down hi...
Celltrion Holdings names J.P. Morgan as advisor
Celltrion Holdings said Thursday it has signed an agreement with J.P. Morgan in move to help facilitate the sell-offs of Celltrion, Celltrion Healthcare Co. and Celltrion Pharm Inc to a multination drug firm.
Under...
FMC Korea to distribute Huons’ injectable anticoagulant in Korea
A local biotech firm Huons said Thursday it has signed a distribution agreement with Fresenius Medical Care Korea (FMC Korea) for an exclusive sales of Huons’ Pine (heparin sodium) injections 20,000 IU and 25,000 IU i...
Survey affirms Koreans drug firms’ preference for U.S. and China
Korean drug companies are keenly interested in making inroads into the U.S. and China for expanding their global network, a survey showed.
According to the survey of 38 innovative drug firms conducted by the state-...
Pfizer Korea wins Lyrica patent infringement case
The Seoul Central District Court ruled Wednesday that CJ Cheil Jedang had infringed on Pfizer’s Lyrica patent.
Lyrica, also known as Pregabalin, is used to treat chronic pain disorders like fibromyalgia and other ...
Local drugmakers enjoy unsolicited gains over Tylenol trouble
Janssen Korea’s competitors are enjoying unexpected benefits these says as the Ministry of Food and Drug Safety (MFDS) on May 16 ordered Janssen Korea to suspend production of five types of medicine for up to five mon...
Austria Biotechnology Forum 2013 to open
Scores of biopharmaceutical industry experts at home and abroad will gathered in Seoul on May 27 to hold a forum on the future of the biopharmaceutical industries in Korea and Austria.
The Austria Biotechnology For...
